DK0437294T3 - Orale farmaceutiske præparater i enhedsdosisform - Google Patents

Orale farmaceutiske præparater i enhedsdosisform

Info

Publication number
DK0437294T3
DK0437294T3 DK91200029.6T DK91200029T DK0437294T3 DK 0437294 T3 DK0437294 T3 DK 0437294T3 DK 91200029 T DK91200029 T DK 91200029T DK 0437294 T3 DK0437294 T3 DK 0437294T3
Authority
DK
Denmark
Prior art keywords
dosage form
unit dosage
oral pharmaceutical
pharmaceutical preparations
cbs
Prior art date
Application number
DK91200029.6T
Other languages
Danish (da)
English (en)
Inventor
Jan Willem Groenendaal
Aart Muhlenbruch
Original Assignee
Yamanouchi Europ Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamanouchi Europ Bv filed Critical Yamanouchi Europ Bv
Application granted granted Critical
Publication of DK0437294T3 publication Critical patent/DK0437294T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/36—Arsenic; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/28—Compounds containing heavy metals
    • A61K31/29—Antimony or bismuth compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK91200029.6T 1990-01-09 1991-01-09 Orale farmaceutiske præparater i enhedsdosisform DK0437294T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90200064 1990-01-09

Publications (1)

Publication Number Publication Date
DK0437294T3 true DK0437294T3 (da) 1994-03-07

Family

ID=8204917

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91200029.6T DK0437294T3 (da) 1990-01-09 1991-01-09 Orale farmaceutiske præparater i enhedsdosisform

Country Status (18)

Country Link
US (1) US5264222A (de)
EP (1) EP0437294B1 (de)
KR (1) KR910014124A (de)
AT (1) ATE101039T1 (de)
AU (1) AU638083B2 (de)
CA (1) CA2033870A1 (de)
DE (1) DE69101111T2 (de)
DK (1) DK0437294T3 (de)
ES (1) ES2063432T3 (de)
FI (1) FI910088A7 (de)
HU (1) HU204707B (de)
IE (1) IE910057A1 (de)
IL (1) IL96904A0 (de)
MY (1) MY106371A (de)
NO (1) NO910080L (de)
NZ (1) NZ236721A (de)
PT (1) PT96437A (de)
ZA (1) ZA91178B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5128140A (en) * 1991-01-14 1992-07-07 The Procter & Gamble Company Swallowable pharmaceutical compositions
US5192752A (en) * 1991-01-14 1993-03-09 The Procter & Gamble Company Swallowable pharmaceutical compositions containing colloidal bismuth subcitrate
GB9120131D0 (en) * 1991-09-20 1991-11-06 Glaxo Group Ltd Medicaments
US6902738B2 (en) 1994-05-02 2005-06-07 Josman Laboratories, Inc. Topical oral dosage forms containing bismuth compounds
US6426085B1 (en) 1994-05-02 2002-07-30 Josman Laboratories Inc. Use of bismuth-containing compounds in topical oral dosage forms for the treatment of halitosis
US5834002A (en) * 1994-05-02 1998-11-10 Josman Laboratories, Inc. Chewing gum containing colloidal bismuth subcitrate
US6379651B1 (en) 1995-02-07 2002-04-30 Josman Laboratories Oral-topical dosage forms for delivering antibacterials/antibiotics to oral cavity to eradicate H. pylori as a concomitant treatment for peptic ulcers and other gastro-intestinal diseases
AU5019196A (en) * 1995-02-07 1996-08-27 Narayan Krishnarao Athanikar Concomitant treatment with oral bismuth compounds
US6372784B1 (en) 1995-02-07 2002-04-16 Josman Laboratories, Inc. Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds
ES2267108T3 (es) * 1995-08-24 2007-03-01 Josman Laboratories, Inc. Composiciones que contienen bismuto en formas de dosificacion topicas.
WO1998022117A1 (en) * 1996-11-22 1998-05-28 The Procter & Gamble Company Compositions for the treatment of gastrointestinal disorders containing bismuth, and nsaid and one or more antimicrobials
EP0941102A1 (de) * 1996-11-22 1999-09-15 The Procter & Gamble Company Zusammensetzungen zur behandlung von gastrointestinalen störungen, welche wismuth und einen nsaid enthalten
DE19913606A1 (de) * 1999-03-25 2000-09-28 Basf Ag Pulverförmige Solubilisationshilfsstoffe für feste pharmazeutische Darreichungsformen
WO2021072350A1 (en) * 2019-10-11 2021-04-15 Tobebio Novel Drug Co., Ltd. Synergistic combination of chemotherapy and peptide for treating cancer
CN111214443A (zh) * 2020-02-23 2020-06-02 北京鑫开元医药科技有限公司 一种枸橼酸铋钾颗粒及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1576376A (en) * 1977-03-30 1980-10-08 Benzon As Alfred Multiple-unit drug dose
US4670245A (en) * 1984-04-27 1987-06-02 Vasquez Tony E Diagnostic procedures using radiolabeled colloidal bismuth subcitrate and related compounds
CA1207239A (en) * 1984-08-10 1986-07-08 Upendra K. Banik Gastrointestinal compositions
WO1986005981A1 (en) * 1985-04-18 1986-10-23 Borody Thomas J Treatment of non-ulcer dyspepsia with bismuth salts
ATE135582T1 (de) * 1985-06-13 1996-04-15 Barry James Marshall Verfahren und zusammensetzungen zur behandlung von gastrointestinalen störungen
GB8612401D0 (en) * 1986-05-21 1986-06-25 Evode Ltd Liquid polmers
DE3874917T2 (de) * 1987-03-09 1993-03-04 Procter & Gamble Zusammensetzungen und ihre verwendung zur behandlung von magen-darmstoerungen.
AU623868B2 (en) * 1987-10-12 1992-05-28 Capability Services Pty. Limited Improved method for treatment of gastrointestinal disorders
EP0375068A1 (de) * 1988-12-23 1990-06-27 Gist-Brocades N.V. Mischungen von Bismuth-Verbindungen und Tetracyclinen

Also Published As

Publication number Publication date
PT96437A (pt) 1991-10-15
HU204707B (en) 1992-02-28
AU638083B2 (en) 1993-06-17
ES2063432T3 (es) 1995-01-01
IL96904A0 (en) 1992-03-29
NO910080L (no) 1991-07-10
EP0437294B1 (de) 1994-02-02
NO910080D0 (no) 1991-01-08
CA2033870A1 (en) 1991-07-10
KR910014124A (ko) 1991-08-31
NZ236721A (en) 1992-08-26
MY106371A (en) 1995-05-30
EP0437294A1 (de) 1991-07-17
ATE101039T1 (de) 1994-02-15
ZA91178B (en) 1991-10-30
DE69101111T2 (de) 1994-07-28
FI910088L (fi) 1991-07-10
FI910088A7 (fi) 1991-07-10
FI910088A0 (fi) 1991-01-07
US5264222A (en) 1993-11-23
DE69101111D1 (de) 1994-03-17
IE910057A1 (en) 1991-07-17
AU6869391A (en) 1991-07-11

Similar Documents

Publication Publication Date Title
IE862554L (en) Pharmaceutical compositions
DK0437294T3 (da) Orale farmaceutiske præparater i enhedsdosisform
GEP20022752B (en) Valaciclovir Tablets Containing Colloidal Silicon Dioxide
FR2682040B1 (fr) Medicaments pour traiter les troubles gastrointestinaux.
MY108146A (en) Medicaments for treating inflammatory conditions or for analgesia
DE3882157D1 (de) Nichtsteroide antientzuendungswirkstoffe enthaltende pharmazeutische zubereitungen.
DE3579730D1 (de) Eisen-3-hydroxypyron- oder 3-hydroxypyridon-komplexe und diese enthaltende pharmazeutische zusammensetzungen.
DE59811768D1 (de) Pharmazeutische kombinationspräparate enthaltend erythropoietin und modifizierte hämoglobine
AU1866888A (en) Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel
DE69323568D1 (de) Antimikrobielle Zusammensetzungen und pharmazeutische Präparate hiervon
FR2675802B1 (fr) Antiserotonines, leur preparation et les medicaments les contenant.
EP0438147A3 (en) Pharmaceutical compositions and dosage forms for the oral administration of calcitonin
NO892764D0 (no) Medikamentell administreringsform for droevtyggere.
DE3576505D1 (de) 3,4-dihydrobenzopyranverbindungen und diese enthaltende pharmazeutische zusammenstellungen.
DE69318153D1 (de) Antihypercholesterämisch-wirksame verbindungen, pharmazeutische präparate und verwendungen davon
IL105774A (en) N-(substituted 2-pyridyl)-6-chloro-4-hydroxy-2-methyl-2h-thieno 2, 3-e9-1, 2-thiazine-3-carboxamide, 1, 1-dioxides their preparation and pharmaceutical compositions containing them
DE68909555D1 (de) Pyridylketoximether-verbindung und diese enthaltende pharmazeutische zusammensetzung.
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
DE69123190D1 (de) Hirudin enthaltende orale Arzneimittel
FR2682108B1 (fr) Acide 3,4-dihydro-4-oxo-3(prop-2-enyl)-1-phtalazineacetiques et derives, leurs preparations et medicaments les contenant.
FR2684299B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique et de l'amiloride.
FR2685204B1 (fr) Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine.
DE3871159D1 (de) Pharmazeutische und tieraerztliche zusammensetzungen.
DE3484155D1 (de) Fr-900216-verbindung, durch kultivierung von atcc 20577 gewonnen, als aktive therapeutische verbindung genutzt, und sie enthaltende antitumorale pharmazeutische zusammensetzung von fr-900216.
KR900700471A (ko) 신규의 2,3-티오모르폴린디온-2-옥심유도체, 이들을 함유하는 약제학적 조성물 및 제법